Brianna Chamberlin is building a reputation for bridging the gap between legal strategy and diverse technologies, ranging from pharmaceutical formulations to mechanical devices to petroleum fracking. Notably, Chamberlin was involved in representing Dainippon Sumitomo Pharma Co. in protecting its best-selling multibillion-dollar branded drug LATUDA. The case was settled on the first day of trial, after which the company’s stock rose nearly 20%. She is Fish’s Minneapolis representative on the firm’s Litigation Associate Advisory Committee, advocating for recruitment and retention of legal talent.